logo
Plus   Neg
Share
Email

Sempra Energy CEO Debra Reed To Retire, Jeffrey Martin To Succeed - Quick Facts

Sempra Energy (SRE) announced that Chairman, President and CEO Debra Reed plans to step down as CEO and president on May 1 and retire on December 1, 2018, after a 40-year career. Reed will continue to serve as Sempra Energy's executive chairman from May until her retirement in December.

The company's board of directors has elected Jeffrey Martin, currently executive vice president and chief financial officer since January 2017, to succeed Reed as CEO. Martin also has been appointed as a new member of Sempra Energy's board, effective May 1.

Joseph Householder, currently corporate group president of infrastructure businesses for Sempra Energy since January 2017, has been elected to succeed Reed as the company's president.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT